2017-02-23,RSI Alert: Foamix Pharmaceuticals Now Oversold
2016-11-28,Foamix To Host Key Opinion Leader Luncheon For Investors Focused On Dermatology, With A Focus On Acne And Rosacea
2016-11-28,Foamix Announces Completion Of Patient Enrollment In Phase 3 Acne Trials For Minocycline Foam FMX101
2016-11-04,Ratings Changes Today
2016-11-03,Foamix Pharmaceuticals To Present At The 25th Annual Credit Suisse Healthcare Conference On November 7
2016-09-28,Foamix Pharmaceuticals Ltd. Announces Pricing Of Its $57 Million Follow-on Offering Of Ordinary Shares
2016-09-27,Foamix Pharmaceuticals Ltd. Announces Proposed Follow-on Offering Of Ordinary Shares
2016-09-06,Foamix To Present Corporate Overview At The Rodman & Renshaw 18th Annual Global Investment Conference
2016-08-10,Foamix Reports Second Quarter 2016 Financial Results And Provides Business Update
2016-08-03,Ratings Changes Today
2016-07-25,Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled For Wednesday, August 10
2016-06-01,Foamix To Present At The BIO International Convention
2016-05-31,Foamix Pharmaceuticals Announces Publication Of Abstract On FDX-104 In The Treatment Of EGFRI Induced Rash For The 2016 ASCO Meeting
2016-05-26,Foamix To Present Corporate Overview At The Jefferies 2016 Healthcare Conference
2016-05-16,Foamix Names Dr. Stanley Hirsch As Chairman, And Dr. Dalia Megiddo As A Member Of The Board Of Foamix Pharmaceuticals
2016-05-10,Foamix Reports First Quarter 2016 Financial Results And Provides Business Update
2016-05-09,Foamix Announces Dosing Of First Patient In Phase 3 Acne Studies For Minocycline Foam FMX101
2016-05-03,Foamix Announces Completion Of Enrollment In Phase 2 Clinical Trial Of Minocycline Foam (FMX103) For Treatment Of Papulopustular Rosacea
2016-04-28,Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled For Tuesday, May 10
2016-03-09,Foamix To Present Corporate Overview At The Barclays Global Healthcare Conference
2016-03-07,Foamix To Present Corporate Overview At The 28th Annual ROTH Conference
2016-03-03,Foamix Reports Fiscal Year 2015 Financial Results And Provides Business Update
2016-02-29,Foamix To Present Corporate Overview At The 36th Annual Cowen & Company Healthcare Conference
2016-02-18,Foamix Pharmaceuticals Fourth Quarter And Fiscal Year 2015 Financial Results Conference Call & Webcast Scheduled For Thursday, March 3
2016-01-28,Foamix Pharmaceuticals Enters Oversold Territory (FOMX)
2016-01-07,Foamix Announces Positive Results From Phase 1 Study To Characterize Minocycline Bioavailability Of FMX-101 Compared To SolodynÂ® (Minocycline HCl) Extended-Release Tablets
2016-01-04,Foamix To Present Corporate Overview At The 3rd Annual Dermatology Summit Meeting
2015-12-31,5 Stocks Under $10 Set to Soar
2015-12-03,Foamix Announces Positive Top-Line Results From Phase II Study For FDX104 (Doxycycline Foam) In The Prevention Of Acneiform Rash Associated With Targeted Antibody Treatments For Colon And Head And Neck Cancers
2015-12-02,Foamix To Host Conference Call & Webcast To Discuss Topline Results From Phase 2 Study Of FDX-104 In Acneiform Rash Associated With Targeted Antibody Treatments For Colon And Head And Neck Cancers
2015-12-01,Foamix To Present Corporate Overview At The Oppenheimer 26th Annual Healthcare Conference
2015-11-12,Ratings Changes Today
2015-11-11,Foamix To Present Corporate Overview At Jefferies Autumn 2015 Global Healthcare Conference In London
2015-11-11,Foamix Reports Third Quarter 2015 Financial Results And Provides Business Update
2015-10-27,Foamix Pharmaceuticals Third Quarter 2015 Conference Call And Webcast Scheduled For Wednesday, November 11
2015-10-20,Foamix Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of FMX103 In Papulopustular Rosacea
2015-08-19,Foamix Reports Second Quarter 2015 Financial Results And Provides Business Update
2015-08-13,Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled For Thursday, August 20
2015-07-31,Finacea(R) (azelaic Acid) Foam 15%, Approved By U.S. FDA For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea
2015-06-16,MERZ North America Makes Milestone Payment To Foamix
2015-06-16,Foamix Receives Milestone Payment From Merz North America
2015-06-01,Foamix To Present Corporate Overview At The Jefferies 2015 Global Healthcare Conference
2015-05-12,Foamix Reports First Quarter Financial Results
2015-05-07,Foamix Announces Appointment Of Dr. Aaron Schwartz To Board Of Directors
2015-04-29,Foamix Pharmaceuticals First Quarter 2015 Conference Call & Webcast Scheduled For Wednesday, May 13
2015-04-20,Foamix Pharmaceuticals Ltd. Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares
2015-04-15,Foamix Pharmaceuticals (FOMX) Stock Spiked Following Pricing of Upsized Offering
2015-04-15,Foamix Pharmaceuticals Ltd. Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares
2015-04-01,Foamix Pharmaceuticals Ltd. Files Registration Statement For Proposed Follow-On Offering
2015-03-18,Foamix Reports Financial Results For The Year Ended December 31, 2014
2015-03-10,Foamix Pharmaceuticals Fourth Quarter 2014 Conference Call & Webcast Scheduled For Wednesday, March 18
2015-03-04,Foamix To Present Corporate Overview At The 27th Annual ROTH Conference
2015-03-03,Foamix To Present Corporate Overview At The Barclays Global Healthcare Conference
2015-02-26,Foamix To Present Corporate Overview At The Cowen & Company 35th Annual Health Care Conference
2014-12-16,Foamix Earns US$ 2.5 Million Milestone Payment From Bayer HealthCare
2014-12-05,Foamix To Present Corporate Overview At The Oppenheimer & Co. 25th Annual Healthcare Conference
2014-11-14,Foamix Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014
2014-11-13,Foamix Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions
2014-11-10,Foamix Pharmaceuticals Third Quarter 2014 Conference Call & Webcast Scheduled For Monday, November 17, 2014
2014-10-29,Foamix Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 4th In New York City
2014-10-24,5 Stocks Under $10 Set to Soar
2014-10-06,Foamix Pharmaceuticals Ltd. Announces Initiation Of Phase II Trial With FDX104 In Chemotherapy Induced Rash
2014-09-23,Foamix Pharmaceuticals Ltd. Announces Closing Of Initial Public Offering
2014-09-18,Foamix Pharmaceuticals (FOMX) Stock Pops After IPO Pricing
2014-09-18,Foamix Pharmaceuticals Ltd. Prices Initial Public Offering
,
,
,
